Non-invasive administration of AAV to target lung parenchymal cells and develop SARS-CoV-2-susceptible mice.
Yang MS, Park MJ, Lee J, Oh B, Kang KW, Kim Y, Lee SM, Lim JO, Jung TY, Park JH, Park SC, Lim YS, Hwang SB, Lyoo KS, Kim DI, Kim B.
Yang MS, et al. Among authors: kim b, kim di, kim y.
Mol Ther. 2022 May 4;30(5):1994-2004. doi: 10.1016/j.ymthe.2022.01.010. Epub 2022 Jan 7.
Mol Ther. 2022.
PMID: 35007757
Free PMC article.